MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517064249 A) filed by Lanova Medicines Limited, Shanghai, on July 4, for 'bispecific antibodies targeting pd1 and vegf.'
Inventor(s) include Li, Runsheng; Cao, Wei; Gu, Haijuan; Huang, Wentao; and Zang, Yingqin.
The application for the patent was published on Aug. 8, under issue no. 32/2025.
According to the abstract released by the Intellectual Property India: "Provided are bispecific antibodies capable of binding to human VEGF protein and human PD-1 protein. These bispecific antibodies are effective in treating cancer."
The patent application was internationally filed on Dec. 08, 2023, under International application No.PCT/CN2023/137517.
Disclaimer: Curated by HT Syndication.
